Read on Twitter
[THREAD] #ClinicalTrials Eligibility [Updated Mar 11, 2020] #ctsm
Modernizing Eligibility Criteria for Molecularly Driven #ClinicalTrials [7/20/15] - @EdKimMDLCI et al. JCO @ASCO_pubs http://ow.ly/RGEdG
metRCC Clinical Trial Participants Differ From Pts Treated in Real-World Practice [9/1/15] Mitchell et al. JCO @ASCO_pubs http://ow.ly/RGBTa #kcsm
Effect PreTx Renal Fn in Adjuvant Tx Older Women w/ BrCA #AllianceNCTN A171201 [1/11/16] Lichtman et al. JCO @ASCO_pubs http://ow.ly/Xkm4M #bcsm
Are Clinical Trial Exclusion Criteria Too Strict? [Jan 12, 2016] @ASHClinicalNews http://ow.ly/JjCm30b1dUR #clinicaltrials #oncopath
Initiative to Modernize Eligibility Criteria for #ClinicalTrials Launched [5/17/16] @ASCO in Action http://ow.ly/fGrq300pMAd
Who’s In and Who’s Out? [11/22/16] @ASHClinicalNews http://ow.ly/WeFL3071OpK
RE: Inclusion/Exclusion criteria in #ClinicalTrials
RE: Inclusion/Exclusion criteria in #ClinicalTrials
How to Succeed in Modernizing Clinical Trials [1/10/17] Eastman @OncologyTimes http://ow.ly/KzVy308l2mq #ClinicalTrials
Analysis of Common Eligibility Criteria of Randomized Controlled Trials in Newly Diagnosed Multiple Myeloma Patients and Extrapolating Outcomes [2/2017] @JatinShahMD & @rabonour1 et al. CLML http://ow.ly/Ci2k30i1jCj #mmsm #ClinicalTrials
Reevaluating Eligibility Criteria: Balancing Patient Protection & Participation [Apr 20, 2017] Beaver, Ison @realrickpazdur @NEJM http://ow.ly/i65N30b0qac #ClinicalTrials
Broadening #ClinicalTrials Eligibility Criteria: @ASCO @CancerResrch - PPT slides & resources including protocol text http://ow.ly/GqQf30fDGdb
Broadening #ClinicalTrials Eligibility Criteria... @ASCO @CancerResrch [10/2/17] @EdKimMDLCI et al. JCO @ASCO_pubs http://ow.ly/aeWM30fDCXs
Modernizing #ClinicalTrials Eligibility: Recs @ASCO @CancerResrch Minimum Age Work Group [10/2/17] Gore et al. JCO @ASCO_pubs http://ow.ly/i5bl30fDDL9
Modernizing #ClinicalTrials I/E @ASCO @CancerResrch Organ Dysfunction, Prior Cancer & Comorbidities [10/2/17] Lichtman et al. JCO @ASCO_pubs http://ow.ly/n0xv30fDEa3
Modernizing #ClinicalTrials I/E: Recs @ASCO @CancerResrch Brain Metastases [10/2/17] Lin et al. JCO @ASCO_pubs http://ow.ly/NtXV30fDF21 #camets
Modernizing #ClinicalTrials I/E: Recs @ASCO @CancerResrch HIV Working Group [10/2/17] Uldrick et al. JCO @ASCO_pubs http://ow.ly/bAxJ30fDFkA #IDOnc
Re-Evaluating I/E Criteria for Oncology #ClinicalTrials: Analysis of IND Apps in 2015 [10/2/17] Jin et al. JCO @ASCO_pubs http://ow.ly/HRqb30fDFI7
Modernizing #ClinicalTrials for Patients With Cancer [Jan 23, 2019] Sharpless ( @NCIDirector) & Doroshow @JAMA_current http://ow.ly/tyLa30nqYg8
Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation [Jan 10, 2019] Unger et al. @JAMAOnc http://ow.ly/Atg730o3v1F #ClinicalTrials @SWOG #SWOGonc
Drivers of Clinical Trial Participation -- Demographics, Disparities, and Eligibility Criteria [Jan 10, 2019] Mishkin, Arnaldez, Ivy @JAMAOnc http://ow.ly/okeU30o3vAc #ClinicalTrials @SWOG #SWOGonc
Impact of broadening clinical trial eligibility criteria for advanced non-small cell lung cancer patients: Real-world analysis - @DrDonaldHarvey et al. #ASCO19 Abstract LBA108 http://ow.ly/zFDM30oR19g #ClinicalTrials #lcsm
Minor kidney dysfunction should not preclude African Americans with AML from enrolling on clinical trials [Dec 7, 2019] @HemOncToday http://ow.ly/5KWu30pZZsJ #AMLsm #ClinicalTrials
Are Racial Disparities in Acute Myeloid Leukemia (AML) Clinical Trial Enrollment Associated with Comorbidities and/or Organ Dysfunction? - @StatlerA16 #ASH19 Abstract 381 http://ow.ly/GxgJ30pZZB7 #AMLsm #ClinicalTrials #cancerdisparities
